Hypertonic glucose pleurodesis for preterm neonates with chylothorax.

Chylothorax is a known complication of postcardiac surgery and the most common cause of pleural effusion in neonates. Conservative management is usually adopted, including Nil-per-Oral (NPO), treatment of underlying etiology of infection, and use of octreotide. Chylothorax resistant to medical therapy and drainage is often treated by chemical pleurodesis. Previously used pleurodesis agents have included talc, minocycline, OK-432, bleomycin, and povidone-iodine. 50% Dextrose (D50) has been reported to be useful for pleurodesis in adults. We successfully managed two cases of prematurely born infants with D50 as an alternative chemical sclerosant for chemical pleurodesis in a resistant chylothorax and discussed evidence of its use in the literature. © 2023 Wiley Periodicals LLC.

Citation

Kam Lun Ellis Hon, Chuk Man Peter Hui, Genevieve P G Fung, Karen K Y Leung, Tak C Yung. Hypertonic glucose pleurodesis for preterm neonates with chylothorax. Pediatric pulmonology. 2023 Jul;58(7):2145-2150

Mesh Tags

Substances

PMID: 37171118

search → result